3-bromo-N-ethylcinnamide,
cinromide,
cinromide, (E)-isomer,
CINROMIDE,
Vumide,
58473-74-8,
trans-3-Bromo-N-ethylcinnamamide,
(E)-m-Bromo-N-ethylcinnamamide,
Cinromide [USAN:INN],
Cinromidum [INN-Latin],
Cinromida [INN-Spanish],
UNII-M197KE7A5N,
BRN 2257983,
2-Propenamide, 3-(3-bromophenyl)-N-ethyl-, (E)-,
M197KE7A5N,
(E)-3-(3-Bromophenyl)-N-ethyl-2-propenamide,
LDCXGZCEMNMWIL-VOTSOKGWSA-N,
(2E)-3-(3-bromophenyl)-N-ethylprop-2-enamide,
NCGC00164530-01,
NCGC00164530-03,
2-Propenamide, 3-(3-bromophenyl)-, (E)-,
DSSTox_CID_26417,
DSSTox_RID_81595,
DSSTox_GSID_46417,
Cinromidum,
Cinromida,
3-(3-Bromophenyl)-N-ethylacrylamide,
(E)-3-(3-Bromophenyl)-N-ethylacrylamide,
CAS-58473-74-8,
3-Bromo-N-ethylcinnamamide,
69449-19-0,
3-Bromo-N-ethylcinnamide,
BW 122U,
3-(3-Bromophenyl)-N-ethyl-2-propenamide,
AC1LELFR,
cinromide, (E)-isomer,
Cinromide (USAN/INN),
SCHEMBL35055,
SCHEMBL35056,
CHEMBL93233,
AC1Q319N,
DTXSID7046417,
GTPL10256,
trans 3-bromo-N-ethylcinnamamide,
ZINC56762,
BW-122U,
CHEBI:135038,
HY-B1274,
Tox21_112161,
NSC335304,
SBB057810,
AKOS008920173,
Tox21_112161_1,
3-(3-Bromophenyl)-N-ethylpropeneamide,
CCG-213086,
FCH4488781,
FCH5486560,
NSC-335304,
trans-3-Bromo-N-ethylcinnamamide, 99%,
NCGC00164530-02,
BBV-38423190,
TS-03434,
LS-123310,
TC-164882,
CS-0013054,
ST51007039,
(E)-3-(3-bromophenyl)-N-ethylprop-2-enamide,
D03513,
AB01563282_01,
SR-01000883703,
(2E)-3-(3-Bromophenyl)-N-ethyl-2-propenamide #,
SR-01000883703-1,
I14-52865,
trans-3-Bromo-N-ethylcinnamamide, technical grade, 90%,
2-Propenamide, (E)-,
C11H12BrNO,
C11-H12-Br-N-O,
CID688145,
(2E)-3-(3-Bromophenyl)-N-ethyl-2-propenamide,